Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Paclitaxel|DRUG: Bevacizumab
Sponsor: George Albert Fisher
Collaborators: Genentech, Inc.|Eli Lilly and Company